BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37489865)

  • 1. Hypoosmosis alters hepatocyte mitochondrial morphology and induces selective release of carbamoyl phosphate synthetase 1.
    Li P; Kuo N; Patel R; Omary MB
    Am J Physiol Gastrointest Liver Physiol; 2023 Oct; 325(4):G334-G346. PubMed ID: 37489865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbamoyl phosphate synthetase-1 is a rapid turnover biomarker in mouse and human acute liver injury.
    Weerasinghe SV; Jang YJ; Fontana RJ; Omary MB
    Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(3):G355-64. PubMed ID: 24924744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of citrulline substitution on clinical outcome after liver transplantation in carbamoyl phosphate synthetase 1 and ornithine transcarbamylase deficiency.
    Aldrian D; Waldner B; Vogel GF; El-Gharbawy AH; McKiernan P; Vockley J; Landau YE; Al Mutairi F; Stepien KM; Kwok AM; Yıldız Y; Honzik T; Kelifova S; Ellaway C; Lund AM; Mori M; Grünert SC; Scholl-Bürgi S; Zöggeler T; Oberhuber R; Schneeberger S; Müller T; Karall D
    J Inherit Metab Dis; 2024 Mar; 47(2):220-229. PubMed ID: 38375550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PGC-1α Promotes Ureagenesis in Mouse Periportal Hepatocytes through SIRT3 and SIRT5 in Response to Glucagon.
    Li L; Zhang P; Bao Z; Wang T; Liu S; Huang F
    Sci Rep; 2016 Apr; 6():24156. PubMed ID: 27052737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive release of CPS1 in bile and its role as a protective cytokine during acute liver injury.
    Park MJ; D'Alecy LG; Anderson MA; Basrur V; Feng Y; Brady GF; Kim DI; Wu J; Nesvizhskii AI; Lahann J; Lukacs NW; Fontana RJ; Omary MB
    Proc Natl Acad Sci U S A; 2019 Apr; 116(18):9125-9134. PubMed ID: 30979808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urea cycle dysregulation in non-alcoholic fatty liver disease.
    De Chiara F; Heebøll S; Marrone G; Montoliu C; Hamilton-Dutoit S; Ferrandez A; Andreola F; Rombouts K; Grønbæk H; Felipo V; Gracia-Sancho J; Mookerjee RP; Vilstrup H; Jalan R; Thomsen KL
    J Hepatol; 2018 Oct; 69(4):905-915. PubMed ID: 29981428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal hyperammonemia and carbamoyl phosphate synthetase 1 (CPS1) deficiency following high-dose chemotherapy and autologous hematopoietic stem cell transplantation.
    Laemmle A; Hahn D; Hu L; Rüfenacht V; Gautschi M; Leibundgut K; Nuoffer JM; Häberle J
    Mol Genet Metab; 2015 Mar; 114(3):438-44. PubMed ID: 25639153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditional disruption of hepatic carbamoyl phosphate synthetase 1 in mice results in hyperammonemia without orotic aciduria and can be corrected by liver-directed gene therapy.
    Khoja S; Nitzahn M; Hermann K; Truong B; Borzone R; Willis B; Rudd M; Palmer DJ; Ng P; Brunetti-Pierri N; Lipshutz GS
    Mol Genet Metab; 2018 Aug; 124(4):243-253. PubMed ID: 29801986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient mitochondrial import of newly synthesized ornithine transcarbamylase (OTC) and correction of secondary metabolic alterations in spf(ash) mice following gene therapy of OTC deficiency.
    Zimmer KP; Bendiks M; Mori M; Kominami E; Robinson MB; Ye X; Wilson JM
    Mol Med; 1999 Apr; 5(4):244-53. PubMed ID: 10448647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ornithine-urea cycle: biosynthesis and regulation of carbamyl phosphate synthetase I and ornithine transcarbamylase.
    Cohen PP
    Curr Top Cell Regul; 1981; 18():1-19. PubMed ID: 7023854
    [No Abstract]   [Full Text] [Related]  

  • 11. Overexpression of carbamoyl-phosphate synthase 1 significantly improves ureagenesis of human liver HepaRG cells only when cultured under shaking conditions.
    Adam AAA; van der Mark VA; Ruiter JPN; Wanders RJA; Oude Elferink RPJ; Chamuleau RAFM; Hoekstra R
    Mitochondrion; 2019 Jul; 47():298-308. PubMed ID: 30802674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Y-box binding protein-1 down-regulates expression of carbamoyl phosphate synthetase-I by suppressing CCAAT enhancer-binding protein-alpha function in mice.
    Chen YR; Sekine K; Nakamura K; Yanai H; Tanaka M; Miyajima A
    Gastroenterology; 2009 Jul; 137(1):330-40. PubMed ID: 19272383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, intracellular transport and processing of mitochondrial urea cycle enzymes.
    Mori M; Miura S; Morita T; Takiguchi M; Tatibana M
    Adv Enzyme Regul; 1983; 21():121-32. PubMed ID: 6545081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling the therapeutic potential of carbamoyl phosphate synthetase 1 (CPS1) in human diseases.
    Zhang L; Zou Y; Lu Y; Li Z; Gao F
    Bioorg Chem; 2023 Jan; 130():106253. PubMed ID: 36356370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation suppresses expression of the urea cycle enzyme carbamoyl phosphate synthetase 1 (CPS1) in human hepatocellular carcinoma.
    Liu H; Dong H; Robertson K; Liu C
    Am J Pathol; 2011 Feb; 178(2):652-61. PubMed ID: 21281797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, intracellular transport, and processing of the precursors for mitochondrial ornithine transcarbamylase and carbamoyl-phosphate synthetase I in isolated hepatocytes.
    Mori M; Morita T; Ikeda F; Amaya Y; Tatibana M; Cohen PP
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6056-60. PubMed ID: 6947214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of ureogenesis.
    Meijer AJ; Lof C; Ramos IC; Verhoeven AJ
    Eur J Biochem; 1985 Apr; 148(1):189-96. PubMed ID: 3979393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A liver-humanized mouse model of carbamoyl phosphate synthetase 1-deficiency.
    Srinivasan RC; Zabulica M; Hammarstedt C; Wu T; Gramignoli R; Kannisto K; Ellis E; Karadagi A; Fingerhut R; Allegri G; Rüfenacht V; Thöny B; Häberle J; Nuoffer JM; Strom SC
    J Inherit Metab Dis; 2019 Nov; 42(6):1054-1063. PubMed ID: 30843237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unfavorable clinical outcomes in patients with carbamoyl phosphate synthetase 1 deficiency.
    Choi Y; Oh A; Lee Y; Kim GH; Choi JH; Yoo HW; Lee BH
    Clin Chim Acta; 2022 Feb; 526():55-61. PubMed ID: 34973183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transport of carbamyl phosphate synthetase I and ornithine transcarbamylase into mitochondria. Inhibition by rhodamine 123 and accumulation of enzyme precursors in isolated hepatocytes.
    Morita T; Mori M; Ikeda F; Tatibana M
    J Biol Chem; 1982 Sep; 257(18):10547-50. PubMed ID: 7107622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.